| 1U2N | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction, 20 Models | resolution | |||||||||||||
| ligand | ZN | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1P4Q, 1R8U | ||||||||||||||
| Primary reference | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding., De Guzman RN, Wojciak JM, Martinez-Yamout MA, Dyson HJ, Wright PE, Biochemistry 2005 Jan 18;44(2):490-7. PMID:15641773 | ||||||||||||||
| Data retrieval |
![]() |
| View 1U2N in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |